FREE Account Opening + No Clearing Fees
Loading...

Avonmore Capital Buyback vs Zydus Lifesciences Buyback

Comparision between Avonmore Capital Buyback and Zydus Lifesciences Buyback.

Buyback Details

Avonmore Capital Buyback is a Tender Offer buyback proposed to list at BSE, NSE while Zydus Lifesciences Buyback is a Tender Offer proposed to list at BSE, NSE.

  Avonmore Capital & Management Services Limited Zydus Lifesciences Limited
Logo Avonmore Capital Buyback Logo Zydus Lifesciences Buyback Logo
Type of Buyback Tender Offer Tender Offer
Listing At BSE, NSE BSE, NSE
Face Value ₹10 per share ₹1 per share
Buyback Price ₹95 per share ₹650 per share
Issue Size 9,17,680 shares 1,15,38,461 shares
Issue Size (Amount) ₹8.72 Crores ₹750.00 Crores
Buyback Ratio
Category Entitlement Ratio of Buyback
Reserved Category for Small Shareholders 36 Equity Share out of every 361 Fully paid-up Equity Shares held on the Record Date.
General Category for all other Eligible Shareholders 5 Equity Shares out of every 147 Fully paid-up Equity Shares held on the Record Date.
Category Entitlement Ratio of Buyback
Reserved Category for Small Shareholders 26 Equity Share out of every 503 Fully paid-up Equity Shares held on the Record Date.
General Category for all other Eligible Shareholders 1 Equity Shares out of every 101 Fully paid-up Equity Shares held on the Record Date.
Registrar Beetal Financial & Computer Services (P) Limited Link Intime India Private Ltd
Lead Managers Corporate Capitalventures Pvt Ltd ICICI Securities Limited
Necessity of the buyback

The buyback is being undertaken for the following reasons:

1. The Buyback will help the company to distribute surplus cash to its shareholders holding Equity shares broadly to the proportion of their shareholding, thereby, enhancing the overall return to shareholders.

2. The Buyback would help in improving its return on equity, by reducing the equity base, thereby leading to a long term increase in shareholders' value.

The buyback is being undertaken for the following reason:

1. The Buyback will help the Company to distribute a part of the surplus cash to its shareholders holding Equity Shares thereby, optimizing returns to the shareholders and enhancing the overall shareholders' value in longer term and improving the return on equity.

Buyback Timetable

Avonmore Capital Buyback and Zydus Lifesciences Buyback buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Avonmore Capital Buyback Buyback record date is Jun 15, 2022. Zydus Lifesciences Buyback Buyback record date is Jun 02, 2022.

  Avonmore Capital & Management Services Limited Zydus Lifesciences Limited
Record Date Jun 15, 2022 Jun 02, 2022
Offer Open Date Jul 04, 2022 Jun 23, 2022
Offer Closure Date Jul 15, 2022 Jul 06, 2022
Last date for receipt of tender forms Jul 18, 2022 Jul 06, 2022
Finalisation of buyback Jul 22, 2022 Jul 14, 2022
Last Date for settlment of bids Jul 25, 2022 Jul 15, 2022
Last Date for extinguishment of shares Aug 01, 2022 Jul 22, 2022

Financial Details and Other Relevent Information

Comparison of Avonmore Capital Buyback and Zydus Lifesciences Buyback financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.

  Avonmore Capital & Management Services Limited Zydus Lifesciences Limited
Financial
Summary of financial Information (Consolidated)
Particulars For the year/period ended (Rs. in Lakh)
  31-Mar-22 31-Mar-21 31-Mar-20
Total Income 8,719.44 7,201.70 7,218.71
Profit After Tax 4,045.02 2,977.74 1,805.27
Net Worth 28,425.92 24,346.62 21,264.59
Reserve and Surplus 18,133.11 14,866.17 12,604.68
Summary of financial Information (Consolidated)
Particulars For the year/period ended (Rs. in Million)
  31-Mar-22 31-Mar-21 31-Mar-20
Total Income 1,54,899 1,51,394 1,43,670
Profit After Tax 23,726 21,850 12,044
Net Worth 1,69,996 1,29,923 1,03,757
Stock price at BSE

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Nov-2021 52.85 40.20 46.82
Dec-2021 77.80 48.00 67.54
Jan-2022 84.90 62.00 68.97

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Apr-2022 376.60 337.70 359.37
Mar-2022 379.00 331.00 359.62
Feb-2022 420.50 343.00 385.95
Stock price at NSE

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Apr-2022 376.70 337.55 359.43
Mar-2022 378.60 331.55 359.63
Feb-2022 420.55 342.85 385.99

Comments

Add a public comment...